Suppression by oxprenolol of adrenergic response to stress.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D001334:Automobile Driving; D001786:Blood Glucose; D002395:Catecholamines / Q000097:blood; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D004644:Emotions; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010096:Oxprenolol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010865:Pilot Projects; D010919:Placebos; D013315:Stress, Psychological; D013565:Sympatholytics / Q000494:pharmacology*; D013610:Tachycardia / Q000517:prevention & control*; D014280:Triglycerides / Q000097:blood
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D001786:Blood Glucose; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D010919:Placebos; D013565:Sympatholytics; D014280:Triglycerides; D010096:Oxprenolol